What is Avitar, Inc. (AVTI)?

Avitar, Inc. (AVTI) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of AVTI?

The current price of AVTI is $0.00. Prices are updated in real time on Stocks360.

What is AVTI's price-to-earnings (PE) ratio?

AVTI's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is AVTI's market capitalization?

AVTI's market capitalization is $1,382.00, placing it in the small-cap tier.

Avitar, Inc. (AVTI)

Stock analysis · OTC · Healthcare · Medical - Specialties

$0.00

Market Cap

$1.38K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-7.73

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

5.00

Avitar, Inc. (AVTI) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.38K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $0.00 2026-10-26 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Avitar, Inc.

Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to e…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	-0.00×
PEG	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-3.10×
EV / Sales	1.67×
Earnings Yield	-1145492.45%
Free Cash Flow Yield	-129502.46%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.17M
Revenue (TTM)	$3.11M
Net Income (TTM)	-$15.83M
Free Cash Flow (TTM)	-$1.25M
Net Debt	$5.17M
Working Capital	-$3.82M
Gross Margin	26.94%
Operating Margin	87.98%
Net Margin	-72.75%
Return on Equity	25.07%
Return on Invested Capital	-203.85%